Sun Pharma Advanced Research Co. Ltd.
EGMFeb. 9, 2026, 4 p.m.
Sr noTypeResolutionIiAS View
1SpecialApprove preferential issue of upto 38,510,000 convertible warrants at a price of Rs. 155.8 each, aggregating ~Rs. 6.0 bn to Shanghvi Finance Private Limited, a promoter group entity
2SpecialApprove SPARC Employees Stock Option Scheme 2026 (ESOP Scheme 2026) under which upto 5.0 mn options can be granted
3SpecialApprove extension of SPARC Employees Stock Option Scheme 2026 (ESOP Scheme 2026) to employees of subsidiaries, holding companies, and associate companies


Enter your details


Summary

Particulars
Meeting Report
+ GST @ 18%
Amount
₹ 6,500
₹ 1,170

Total
₹ 7,670